Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis
Condition: Lupus Nephritis Interventions: Drug: Mescaline sodium enteric-coated tablets; Drug: Morte-mescaline; Drug: Glucocorticoids Sponsors: Xiangya Hospital of Central South University; Beijing Medical Award Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Lupus Landmark Study: A Prospective Registry and Biorepository
Conditions: Systemic Lupus Erythematosus (SLE); Lupus Nephritis; Neuropsychiatric Systemic Lupus Erythematosus Intervention: Sponsor: Lupus Research Alliance Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis
Condition: Lupus Nephritis Interventions: Drug: Mescaline sodium enteric-coated tablets; Drug: Morte-mescaline; Drug: Glucocorticoids Sponsors: Xiangya Hospital of Central South University; Beijing Medical Award Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Lupus Landmark Study: A Prospective Registry and Biorepository
Conditions: Systemic Lupus Erythematosus (SLE); Lupus Nephritis; Neuropsychiatric Systemic Lupus Erythematosus Intervention: Sponsor: Lupus Research Alliance Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis
Condition: Lupus Nephritis Interventions: Drug: Mescaline sodium enteric-coated tablets; Drug: Morte-mescaline; Drug: Glucocorticoids Sponsors: Xiangya Hospital of Central South University; Beijing Medical Award Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Lupus Landmark Study: A Prospective Registry and Biorepository
Conditions: Systemic Lupus Erythematosus (SLE); Lupus Nephritis; Neuropsychiatric Systemic Lupus Erythematosus Intervention: Sponsor: Lupus Research Alliance Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis
Condition: Lupus Nephritis Interventions: Drug: Mescaline sodium enteric-coated tablets; Drug: Morte-mescaline; Drug: Glucocorticoids Sponsors: Xiangya Hospital of Central South University; Beijing Medical Award Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Lupus Landmark Study: A Prospective Registry and Biorepository
Conditions: Systemic Lupus Erythematosus (SLE); Lupus Nephritis; Neuropsychiatric Systemic Lupus Erythematosus Intervention: Sponsor: Lupus Research Alliance Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis
Condition: Lupus Nephritis Interventions: Drug: Mescaline sodium enteric-coated tablets; Drug: Morte-mescaline; Drug: Glucocorticoids Sponsors: Xiangya Hospital of Central South University; Beijing Medical Award Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
Lupus Landmark Study: A Prospective Registry and Biorepository
Conditions: Systemic Lupus Erythematosus (SLE); Lupus Nephritis; Neuropsychiatric Systemic Lupus Erythematosus Intervention: Sponsor: Lupus Research Alliance Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials
CNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus
Conditions: Refractory Systemic Lupus Erythematosus; Lupus Nephritis; Immune Thrombocytopenia Intervention: Drug: CNCT19 cell injection Sponsor: Peking Union Medical College Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 5, 2023 Category: Research Source Type: clinical trials